Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuvalent Inc Cl A (NUVL)

Nuvalent Inc Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,588,745
  • Shares Outstanding, K 71,053
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,220 K
  • EBIT $ -241 M
  • EBITDA $ -251 M
  • 60-Month Beta 1.33
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.26

Options Overview Details

View History
  • Implied Volatility 40.87% ( -2.39%)
  • Historical Volatility 39.53%
  • IV Percentile 3%
  • IV Rank 3.30%
  • IV High 92.79% on 08/20/24
  • IV Low 39.09% on 09/23/24
  • Put/Call Vol Ratio 0.01
  • Today's Volume 87
  • Volume Avg (30-Day) 326
  • Put/Call OI Ratio 1.49
  • Today's Open Interest 21,141
  • Open Int (30-Day) 21,054

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.01
  • Number of Estimates 6
  • High Estimate -0.84
  • Low Estimate -1.28
  • Prior Year -0.62
  • Growth Rate Est. (year over year) -62.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.38 +8.61%
on 11/18/24
103.62 -10.51%
on 10/22/24
-8.43 (-8.34%)
since 10/21/24
3-Month
80.80 +14.76%
on 09/12/24
113.51 -18.31%
on 09/16/24
+10.07 (+12.18%)
since 08/21/24
52-Week
59.99 +54.58%
on 11/22/23
113.51 -18.31%
on 09/16/24
+32.73 (+54.55%)
since 11/21/23

Most Recent Stories

More News
Promising Progress in Oncology as Cancer Deaths Decline and Research Grows

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – With the recent wrapping up of...

ONCY : 0.9800 (-1.85%)
CORT : 55.92 (-0.30%)
ILMN : 136.99 (+4.03%)
CSTL : 28.88 (+1.51%)
NUVL : 92.73 (+1.71%)
ONC.TO : 1.37 (-2.14%)
Tech Stocks Close Lower on Weakness in Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.47%. Stocks...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-230 (+0.20%)
AAPL : 228.52 (-0.21%)
QRVO : 67.87 (+3.37%)
SWKS : 85.05 (+1.94%)
ARM : 133.14 (-0.42%)
MU : 102.76 (+4.46%)
Stocks Pressured by Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.92%. Stocks today are mixed,...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-230 (+0.20%)
AAPL : 228.52 (-0.21%)
QRVO : 67.87 (+3.37%)
SWKS : 85.05 (+1.94%)
ARM : 133.14 (-0.42%)
MU : 102.76 (+4.46%)
Stocks Pressured by Weakness in Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.84%. Stocks today are mixed,...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-230 (+0.20%)
AAPL : 228.52 (-0.21%)
MU : 102.76 (+4.46%)
ARM : 133.14 (-0.42%)
NVDA : 146.67 (+0.53%)
AVGO : 163.94 (+0.42%)
Why Nuvalent Stock Tanked on Tuesday

The dilution monster stalked the company following the announcement of a new capital-raising effort.

PIPR : 340.34 (+1.86%)
NUVL : 92.73 (+1.71%)
Nuvalent Announces Pricing of Public Offering of Common Stock

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 92.73 (+1.71%)
Nuvalent Announces Public Offering of Common Stock

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 92.73 (+1.71%)
Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial that Support Best-In-Class Potential of NVL-655 for Patients with ALK-Positive NSCLC

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 92.73 (+1.71%)
Why Nuvalent Stock Skyrocketed 35% This Week

Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.

NUVL : 92.73 (+1.71%)
Why Nuvalent Stock Was Soaring Wednesday

The company reported preliminary data on a non-small cell lung cancer therapy.

NUVL : 92.73 (+1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Nuvalent Inc. is a biopharmaceutical company. It focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. The company's program pipeline includes ROS1-positive and ALK-positive NSCLC. Nuvalent Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 99.30
2nd Resistance Point 96.94
1st Resistance Point 94.84
Last Price 92.73
1st Support Level 90.37
2nd Support Level 88.01
3rd Support Level 85.90

See More

52-Week High 113.51
Fibonacci 61.8% 93.07
Last Price 92.73
Fibonacci 50% 86.75
Fibonacci 38.2% 80.43
52-Week Low 59.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar